Pacira BioSciences, Inc. Quarterly Cost of Revenue in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Pacira BioSciences, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2010 to Q2 2024.
  • Pacira BioSciences, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $44.3M, a 8.18% decline year-over-year.
  • Pacira BioSciences, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $179M, a 14.6% decline year-over-year.
  • Pacira BioSciences, Inc. annual Cost of Revenue for 2023 was $185M, a 7.34% decline from 2022.
  • Pacira BioSciences, Inc. annual Cost of Revenue for 2022 was $199M, a 42.1% increase from 2021.
  • Pacira BioSciences, Inc. annual Cost of Revenue for 2021 was $140M, a 19.5% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $179M $44.3M -$3.95M -8.18% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $183M $47.4M -$1.6M -3.27% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $185M $47.7M -$14.2M -23% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $199M $39.8M -$10.9M -21.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $210M $48.2M -$2.42M -4.78% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $212M $49M +$12.9M +35.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $199M $61.9M +$22.9M +58.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $176M $50.7M +$16M +46.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $160M $50.6M +$15.4M +43.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $145M $36.1M +$4.73M +15.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $140M $39M +$3.71M +10.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $137M $34.7M +$4.66M +15.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $132M $35.2M +$12.9M +58% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $119M $31.3M +$1.62M +5.44% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $117M $35.3M +$3.39M +10.6% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 $114M $30M +$7.69M +34.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $106M $22.3M -$2.9M -11.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $109M $29.7M +$2.43M +8.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $107M $31.9M +$7.93M +33.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $98.8M $22.3M +$3.24M +17% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 $95.5M $25.2M +$4.29M +20.5% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 $91.3M $27.3M +$4.42M +19.3% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 $86.8M $24M +$2.68M +12.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-21
Q3 2018 $84.2M $19.1M +$837K +4.59% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-21
Q2 2018 $83.3M $20.9M -$2.9M -12.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-21
Q1 2018 $86.2M $22.9M -$1.7M -6.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-21
Q4 2017 $87.9M $21.3M -$2.33M -9.85% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $90.2M $18.2M -$24.9M -57.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 $115M $23.8M +$758K +3.29% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 $114M $24.6M +$4.3M +21.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 $110M $23.6M +$4.19M +21.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 $106M $43.2M +$27.3M +171% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 $78.7M $23.1M +$4.12M +21.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-28
Q1 2016 $74.5M $20.3M +$2.7M +15.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-28
Q4 2015 $71.8M $19.4M -$58M -74.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 $130M $15.9M -$4.49M -22% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 $134M $18.9M -$1.03M -5.14% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 $135M $17.6M -$547K -3.02% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 $136M $77.4M +$59.1M +321% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $76.8M $20.4M +$5.6M +37.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 $71.2M $20M +$9.74M +95.4% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 $61.5M $18.1M +$6.74M +59.1% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-25
Q4 2013 $54.8M $18.4M +$8.7M +90% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-24
Q3 2013 $46.1M $14.8M +$5.5M +59.3% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-24
Q2 2013 $40.6M $10.2M +$3.53M +52.8% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-24
Q1 2013 $37M $11.4M +$4.9M +75.4% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-24
Q4 2012 $32.1M $9.67M +$3.07M +46.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-25
Q3 2012 $29.1M $9.29M +$5.93M +177% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-25
Q2 2012 $23.1M $6.69M +$3.57M +115% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-25
Q1 2012 $19.6M $6.5M +$2.83M +77.1% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-25
Q4 2011 $16.7M $6.6M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $3.36M -$216K -6.05% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $3.12M +$266K +9.34% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $3.67M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 $3.57M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $2.85M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.